ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,570.41
1.08%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. NeuroOne Medical Technologies Corporation (NMTC)

  7. NeuroOne Medical Technologies Corporation (NMTC) Noticias

NMTC NeuroOne Medical Technologies Corporation

1.1899
-0.0201 (-1.66%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
NeuroOne Medical Technologies Corporation NMTC NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.0201 -1.66% 1.1899 18:19:56
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.23 1.15 1.231 1.17 1.21
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
10/4/202408:00GLOBENeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
09/4/202408:05GLOBENeuroOne® Announces First Implant of OneRF™ Ablation..
04/4/202408:00GLOBENeuroOne® CEO Dave Rosa Featured on Fox Business Network’s..
26/3/202408:00GLOBENeuroOne® Initiates Limited Commercial Launch of OneRF™..
08/3/202411:00GLOBENeuroOne® to Participate in the 36th Annual Roth Conference
04/3/202413:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202413:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202412:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202416:10GLOBENeuroOne Reports Inducement Grant Under Nasdaq Listing Rule..
21/2/202410:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202409:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202409:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202409:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202415:15EDGAR2Form 8-K - Current report
13/2/202415:00GLOBENeuroOne® Reports First Quarter Fiscal Year 2024 Financial..
08/2/202414:30GLOBENeuroOne® to Report First Quarter Fiscal Year 2024 Financial..
01/2/202412:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202412:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202412:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202415:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/1/202408:02EDGAR2Form ARS - Annual Report to Security Holders
29/1/202408:00EDGAR2Form DEF 14A - Other definitive proxy statements
05/1/202415:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/1/202412:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202412:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202412:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202317:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202315:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202315:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202308:35EDGAR2Form 144 - Report of proposed sale of securities
15/12/202315:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/12/202315:39EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
14/12/202315:30EDGAR2Form 8-K - Current report
14/12/202315:15GLOBENeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year..
11/12/202307:15EDGAR2Form 8-K - Current report
11/12/202307:00GLOBENeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™..
07/12/202315:30GLOBENeuroOne® to Report Fourth Quarter and Fiscal Year 2023..
04/12/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202315:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202315:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202315:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/11/202307:00EDGAR2Form 8-K - Current report
16/11/202307:00GLOBENeuroOne® Announces Patent Allowance for Drug Delivery..
14/11/202316:15GLOBENeuroOne® Appoints Medtech Executive Christopher R. Volker..
13/11/202317:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202316:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202316:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202316:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202307:15EDGAR2Form 8-K - Current report
07/11/202307:00GLOBENeuroOne® Provides Progress Update on FDA 510(k) Submission..

Su Consulta Reciente

NASDAQ
NMTC
NeuroOne Medical Technol...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados